No profile data available.
HH Biotechnology Holdings Company (HHBT) is a financial services company in the property transaction services industry, based in Shenyang, China, with about 121 full-time employees.
It reported revenue of $7.99 million for fiscal year 2015, about flat from fiscal year 2014, and net income of $2.48 million. In Q3 2016 (the quarter ended September 30, 2016) revenue was $1.95 million, up 10.2% from a year before. Its market capitalization was $1,405 as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2015; market data as of October 8, 2026.
HH Biotechnology Holdings Company engages in health and green industries. It focuses on planting and supplying macadamia nuts for use in foods, cooking oils, healthy products, toiletries, and cosmetics. The company was formerly known as Great China International Holdings, Inc. and changed its name to HH Biotechnology Holdings Company in August 2016.
HH Biotechnology Holdings reported $7.99 million in revenue for fiscal year 2015, about flat from $7.99 million in fiscal year 2014. In Q3 2016 revenue was $1.95 million.
$1,405 as of October 8, 2026.
Listed companies of a similar size in the same industry (property transaction services) include Omagine, Inc. (OMAGQ), Manufactured Housing Properties Inc. (MHPC), Stratus Capital Corp. (SRUS), Djsp Enterprises, Inc. (DJSP).